UBS Group Valuation

Is UBS N undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of UBS N when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: UBS N (MX$652.49) is trading above our estimate of fair value (MX$30.34)

Significantly Below Fair Value: UBS N is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for UBS N?

Key metric: As UBS N is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for UBS N. This is calculated by dividing UBS N's market cap by their current earnings.
What is UBS N's PE Ratio?
PE Ratio22.6x
EarningsUS$4.52b
Market CapUS$101.91b

Price to Earnings Ratio vs Peers

How does UBS N's PE Ratio compare to its peers?

The above table shows the PE ratio for UBS N vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average13.3x
MQG Macquarie Group
23.7x9.9%AU$83.9b
DBK Deutsche Bank
7.9x13.4%€30.5b
BPAC11 Banco BTG Pactual
13.8x14.5%R$158.6b
GPROFUT * Grupo Profuturo. de
7.7xn/aMex$27.1b
UBS N UBS Group
22.6x25.6%Mex$90.3b

Price-To-Earnings vs Peers: UBS N is expensive based on its Price-To-Earnings Ratio (22.6x) compared to the peer average (13.2x).


Price to Earnings Ratio vs Industry

How does UBS N's PE Ratio compare vs other companies in the South American Capital Markets Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
UBS N 22.6xIndustry Avg. 9.4xNo. of Companies8PE0612182430+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: UBS N is expensive based on its Price-To-Earnings Ratio (22.6x) compared to the South American Capital Markets industry average (9.4x).


Price to Earnings Ratio vs Fair Ratio

What is UBS N's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

UBS N PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio22.6x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate UBS N's Price-To-Earnings Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst UBS N forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Currentn/a
Mex$678.32
0%
17.5%Mex$983.30Mex$481.33n/a17
Nov ’25Mex$644.00
Mex$675.86
+4.9%
17.7%Mex$994.46Mex$486.80n/a17
Oct ’25Mex$589.31
Mex$672.03
+14.0%
14.8%Mex$869.49Mex$492.16n/a18
Sep ’25Mex$608.94
Mex$651.99
+7.1%
15.7%Mex$847.77Mex$479.87n/a17
Aug ’25n/a
Mex$599.83
0%
15.0%Mex$775.00Mex$439.86n/a17
Jul ’25Mex$549.00
Mex$527.05
-4.0%
14.5%Mex$681.54Mex$386.82n/a18
Jun ’25Mex$527.00
Mex$527.05
+0.009%
14.5%Mex$681.54Mex$386.82n/a18
May ’25Mex$451.21
Mex$524.50
+16.2%
13.6%Mex$691.67Mex$392.57n/a18
Apr ’25Mex$510.31
Mex$516.04
+1.1%
19.4%Mex$686.68Mex$244.98n/a18
Mar ’25Mex$479.35
Mex$522.57
+9.0%
17.1%Mex$636.84Mex$254.74n/a19
Feb ’25Mex$499.00
Mex$530.99
+6.4%
20.1%Mex$676.42Mex$261.84n/a19
Jan ’25n/a
Mex$523.92
0%
20.3%Mex$683.45Mex$261.49n/a19
Dec ’24Mex$444.00
Mex$526.13
+18.5%
20.3%Mex$684.14Mex$261.76n/a19
Nov ’24n/a
Mex$529.12
0%
20.0%Mex$674.48Mex$264.19Mex$644.0019
Oct ’24Mex$440.00
Mex$486.08
+10.5%
22.3%Mex$666.48Mex$251.36Mex$589.3119
Sep ’24Mex$443.85
Mex$431.52
-2.8%
19.4%Mex$578.74Mex$254.65Mex$608.9419
Aug ’24Mex$366.55
Mex$421.36
+15.0%
18.9%Mex$532.69Mex$255.69n/a19
Jul ’24Mex$338.99
Mex$427.15
+26.0%
17.6%Mex$571.59Mex$305.87Mex$549.0018
Jun ’24n/a
Mex$415.18
0%
19.3%Mex$582.97Mex$257.36Mex$527.0017
May ’24Mex$358.00
Mex$429.12
+19.9%
18.6%Mex$608.78Mex$268.76Mex$451.2118
Apr ’24Mex$354.00
Mex$426.90
+20.6%
21.3%Mex$701.37Mex$260.06Mex$510.3117
Mar ’24n/a
Mex$445.50
0%
18.7%Mex$712.69Mex$264.26Mex$479.3520
Feb ’24Mex$405.00
Mex$444.21
+9.7%
19.1%Mex$729.48Mex$270.48Mex$499.0020
Jan ’24Mex$361.23
Mex$440.55
+22.0%
15.5%Mex$640.19Mex$296.77n/a19
Dec ’23Mex$349.00
Mex$410.07
+17.5%
15.6%Mex$556.43Mex$269.04Mex$444.0019
Nov ’23Mex$300.00
Mex$397.18
+32.4%
15.9%Mex$540.20Mex$261.20n/a19

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies